v3.26.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities:    
Net income $ 177.2 $ 625.8
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Depreciation 198.9 187.3
Amortization of intangibles 51.1 54.0
Stock compensation expense 34.6 25.0
Impairment charges 2.1 7.3
Loss on sale of business 0.0 12.3
Gain on sale of investment in affiliate 0.0 (251.9)
Equity in net earnings of affiliates, net of cash received (32.1) (30.0)
Deferred income tax benefit (96.5) (348.8)
Other 3.5 23.4
Changes in operating assets and liabilities:    
Accounts and notes receivable, net (181.3) 81.1
Inventories, net (302.4) (113.4)
Other current and noncurrent assets 19.7 (29.2)
Accounts payable 103.1 98.6
Accrued expenses (225.3) (241.4)
Other current and noncurrent liabilities 29.0 124.4
Total adjustments (395.6) (401.3)
Net cash provided by (used in) operating activities (218.4) 224.5
Cash flows from investing activities:    
Purchases of property, plant and equipment (162.2) (159.3)
Proceeds from sale of property, plant and equipment 0.3 1.7
Proceeds from sale of business 0.0 (12.3)
Investments in unconsolidated affiliates (35.0) (1.2)
Proceeds from sale of investments in unconsolidated affiliates 188.4 260.0
Other (15.7) (7.7)
Net cash provided by (used in) investing activities (24.2) 81.2
Cash flows from financing activities:    
Proceeds from indebtedness 344.6 481.6
Repayments of indebtedness (69.1) (458.0)
Purchases and retirement of common stock (403.7) 0.0
Payment of dividends to stockholders (62.7) (64.9)
Payment of minimum tax withholdings on stock compensation (7.7) (11.4)
Net cash used in financing activities (198.6) (52.7)
Effects of exchange rate changes on cash, cash equivalents and restricted cash (5.5) 18.4
Increase (decrease) in cash, cash equivalents and restricted cash (446.7) 271.4
Cash, cash equivalents and restricted cash, beginning of period 861.8 612.7
Cash, cash equivalents and restricted cash, end of period $ 415.1 $ 884.1